Showing results (121-130 of 201) with videos related to
Sort By:
Pageof 21
Psoriasis (Auckland, N.Z.)|September 1, 2017
Erythrodermic psoriasis: pathophysiology and current treatment perspectivesRasnik K Singh, Kristina M Lee, Derya Ucmak, et al.Psoriasis (Auckland, N.Z.)|June 2, 2022
Comorbid Psoriasis and Metabolic Syndrome: Clinical Implications and Optimal ManagementEveline De Brandt, Tom HillaryPsoriasis (Auckland, N.Z.)|May 9, 2022
Updated Perspectives on Keratinocytes and Psoriasis: Keratinocytes are More Than Innocent BystandersLaura I Ortiz-Lopez, Vivek Choudhary, Wendy B BollagPsoriasis (Auckland, N.Z.)|June 30, 2022
Dietary Intervention and Supplements in the Management of Psoriasis: Current PerspectivesMimi Chung, Erin Bartholomew, Samuel Yeroushalmi, et al.Psoriasis (Auckland, N.Z.)|July 8, 2021
An Association of Pediatric Psoriasis with Metabolic Syndrome in Thai Children: 20 Years Retrospective StudyParichat Mhusakunchai, Leelawadee TechasatianPsoriasis (Auckland, N.Z.)|January 2, 2026
Real-World Experience of Guselkumab in the Elderly PopulationZeno Fratton, Stefano Bighetti, Luca Bettolini, et al.Psoriasis (Auckland, N.Z.)|June 16, 2022
Bimekizumab for the Treatment of Psoriasis: A Review of the Current KnowledgeAngelo Ruggiero, Luca Potestio, Elisa Camela, et al.Psoriasis (Auckland, N.Z.)|August 24, 2019
Serum TSLP is a potential biomarker of psoriasis vulgaris activityMohamed Ibrahim El-Ghareeb, Afaf Helmy, Sally Al Kazzaz, et al.Psoriasis (Auckland, N.Z.)|May 17, 2018
Low starting dosage of infliximab with possible escalating dosage in psoriatic arthritis gives the same treatment results as standard dosage of adalimumab or etanercept: results from the nationwide Icelandic ICEBIO registryBjorn Gudbjornsson, Arni Jon Geirsson, Niels Steen KroghPsoriasis (Auckland, N.Z.)|August 22, 2025
Causal Effect of Plasma Fatty Acid Profiles on Psoriasis Risk: Genetic Evidence from a Mendelian Randomization StudyLei Yao, Xi Wang, Dongmei Lu, et al.Pageof 21